Induced Pluripotent Stem Cells

iPSC are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications, but also for basic research fields, such as development, cancer, epigenetics and aging.

    Related Conference of Induced Pluripotent Stem Cells

    May 19-20, 2025

    8th Global Conference on Cell and Gene Therapy

    Singapore City, Singapore
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany
    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain

    Induced Pluripotent Stem Cells Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in